Quantcast
Last updated on April 17, 2014 at 11:16 EDT

Latest Amines Stories

2014-04-04 08:24:45

-- Clinically meaningful improvement in quality of life with single injection of resiniferatoxin SAN DIEGO, April 4, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that investigators from the National Institutes of Health (NIH) presented data highlighting results from the first two dosing cohorts of the Phase I/II trial of...

Ketamine May Help Treat Severe Depression
2014-04-03 10:32:36

Brett Smith for redOrbit.com - Your Universe Online Once considered an illicit street drug, marijuana is currently being seen in a new light – with many patients and doctors touting the benefits of regular cannabis treatments. Another current street drug, ketamine, is now being looked at for its therapeutic value as a new study from UK researchers at Oxford University has found that relatively small doses of the drug are effective in treating depression. According to the team’s...

2014-04-03 08:28:55

Product has fast track designation by FDA RALEIGH, N.C., April 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy. The Phase 3 trial is a multicenter, randomized, double blind, placebo controlled study to determine the efficacy and safety of Clonidine Topical Gel in the treatment...

2014-04-01 08:28:22

MONMOUTH JUNCTION, N.J., April 1, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced several key management changes, including the new appointment of Mr. Stephen J. Kovary to the position of Vice President of Operations. Mr. Kovary brings three decades of pharmaceutical experience in the areas of manufacturing, process improvement, facilities, engineering, plant and systems management. Prior to...

2014-03-30 23:21:40

Data includes how to contact national network of attorneys for no-cost consultations to consumers seeking compensation over allegations that children suffered birth defects due to mothers’ use of Zoloft, Prozac, Celexa, Luvox, Paxil, Lexapro or Viibryd during pregnancies. San Diego, CA (PRWEB) March 30, 2014 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today that it has established an information site for consumers who are...

2014-03-26 11:23:23

Presentations at the 4th European Lung Cancer Conference A new era of lung cancer therapy is close to dawning, using drugs that can prevent tumor cells from evading the immune system, experts have said at the 4th European Lung Cancer Congress. For decades, scientists and doctors thought immunotherapy –treatments that harness the immune system to fight a disease-- was of marginal benefit in lung cancer, says Jean-Charles Soria, Institute Gustave Roussy in Paris, France. However a...

2014-03-25 00:23:16

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rt6msb/investigation) has announced the addition of the "Investigation Report on China Duloxetine Market" [http://www.researchandmarkets.com/research/rt6msb/investigation ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Depression is a common mood disorder that belongs to high-incidence mental...

2014-03-20 08:23:29

DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/4cd2fp/edta_tetrasodium) has announced the addition of the "Edta Tetrasodium (CAS 64-02-8) Market Research Report" [http://www.researchandmarkets.com/research/4cd2fp/edta_tetrasodium ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Edta Tetrasodium (CAS 64-02-8) Market Research Report presents...

2014-03-14 08:22:12

DUBLIN, Mar. 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2bxsht/dimethylamine ) has announced the addition of the "Dimethylamine (CAS 124-40-3) Market Research Report 2013" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Dimethylamine (CAS 124-40-3) Market Research Report presents comprehensive data on dimethylamine markets globally and regionally (Europe, Asia, North America etc.) The Dimethylamine (CAS...

2014-03-11 23:32:47

Reliable Biopharmaceutical Corporation announces the launch of cGMP HEPES buffer to serve the biopharmaceutical industry. St. Louis, Missouri (PRWEB) March 11, 2014 cGMP HEPES Buffer is used in many critical processes by the biopharmaceutical industry. As regulations surrounding supply chain and excipient quality become more stringent, there is a need for high quality GMP commercial ingredient manufacturing. Reliable’s cGMP HEPES Buffer is manufactured following stringent cGMP...